bioMérieux – First-Half 2016 Results
31 Agosto, 2016
bioMérieux – Second-Quarter 2016 Business Review
18 Luglio, 2016
Strong growth in sales, up 10.9%, at constant exchange rates and scope of consolidation in the first half of 2016: Sales reached €1,001 million Up 7.2% as reported Growth continued to be led by the Americas in the second quarter, supported by the return to faster gains in the Asia-Pacific region All of the clinical and industrial lines contributed to consolidated growth Excellent 62% increase in FilmArray® sales in the second quarter
bioMérieux amplia la capacità di identificazione dei patogeni sul sistema VITEK® MS
06 Luglio, 2016
With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases.
bioMérieux riceve l'approvazione dell'FDA per il più ampio utilizzo di VIDAS® B•R•A•H•M•S PCT™ per la gestione di pazienti con sepsi ad elevato rischio di mortalità
01 Luglio, 2016
Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients
bioMérieux acquisisce Hyglos
01 Giugno, 2016
bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products
bioMérieux e l’Università di Antwerp svelano i risultati finali della prima Global Point Prevalence Survey sull’utilizzo degli antibiotici e sui relativi tassi di resistenza negli ospedali
11 Aprile, 2016
Huge discrepancies in antibiotic use practices between countries 2nd line antibiotics2 too frequently prescribed.
FilmArray® Torch ha ricevuto l’approvazione FDA per tutti e quattro i Pannelli attualmente commercializzati e il Sistema ottiene il marchio CE/IVD.
08 Aprile, 2016
BioFire receives FDA clearances for FilmArray® Torch with FilmArray® Blood Culture Identification Panel, Gastrointestinal Panel and Meningitis/Encephalitis Panel FilmArray® Torch delivers high throughput, radically smaller footprint.
bioMérieux – First-Quarter 2016 Business Review
04 Aprile, 2016
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2016.
bioMérieux – 2015 Financial Results
02 Marzo, 2016